The effect of 6-year osteoporosis treatment withzoledronic 5 mg (aclasta) in comparison with 3-yeartreatment: results from the horizon-pft.
oleh: D Black, I. R. Reid, J. A. Cauley, S Boonen, F Cosman, P C Leung, P Lakatos, Z Man, S. R. Cummings, T. F. Hue, M. E. Ruzycky, R Martinez, G Su, C Bucci-Rechtweg, R Eastell
| Format: | Article |
|---|---|
| Diterbitkan: | Endocrinology Research Centre 2011-04-01 |
Deskripsi
No description available for this item.